Among patients who don't mount a high antibody response to vaccination, would an extra booster dose be helpful?
Could the COVID-19 vaccine trigger the onset of MS in those who are already at a higher risk of developing it, such as direct relatives of people diagnosed with MS?
Does the COVID-19 vaccine have the potential to help resolve residual neurological symptoms in people with MS, based on evidence of improvement in fatigue and cognitive issues seen in COVID long haulers?
